291 related articles for article (PubMed ID: 32774148)
41. Resolvin D3 improves the impairment of insulin signaling in skeletal muscle and nonalcoholic fatty liver disease through AMPK/autophagy-associated attenuation of ER stress.
Oh H; Cho W; Abd El-Aty AM; Bayram C; Jeong JH; Jung TW
Biochem Pharmacol; 2022 Sep; 203():115203. PubMed ID: 35948170
[TBL] [Abstract][Full Text] [Related]
42. Hepatic lipid accumulation: cause and consequence of dysregulated glucoregulatory hormones.
Geisler CE; Renquist BJ
J Endocrinol; 2017 Jul; 234(1):R1-R21. PubMed ID: 28428362
[TBL] [Abstract][Full Text] [Related]
43. SIRT2 Deficiency Exacerbates Hepatic Steatosis via a Putative Role of the ER Stress Pathway.
Leal H; Cardoso J; Valério P; Quatorze M; Carmona V; Cunha-Santos J; Pereira de Almeida L; Pereira C; Cavadas C; Gomes P
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743232
[TBL] [Abstract][Full Text] [Related]
44. Fenofibrate, but not ezetimibe, prevents fatty liver disease in mice lacking phosphatidylethanolamine
van der Veen JN; Lingrell S; Gao X; Takawale A; Kassiri Z; Vance DE; Jacobs RL
J Lipid Res; 2017 Apr; 58(4):656-667. PubMed ID: 28159867
[TBL] [Abstract][Full Text] [Related]
45. Impaired ferritinophagy flux induced by high fat diet mediates hepatic insulin resistance via endoplasmic reticulum stress.
Jiang C; Zhang S; Li D; Chen L; Zhao Y; Mei G; Liu J; Tang Y; Gao C; Yao P
Food Chem Toxicol; 2020 Jun; 140():111329. PubMed ID: 32283200
[TBL] [Abstract][Full Text] [Related]
46. Hesperidin suppresses ERS-induced inflammation in the pathogenesis of non-alcoholic fatty liver disease.
Xie Q; Gao S; Lei M; Li Z
Aging (Albany NY); 2022 Feb; 14(3):1265-1279. PubMed ID: 35143415
[TBL] [Abstract][Full Text] [Related]
47. Understanding the Role of Perilipin 5 in Non-Alcoholic Fatty Liver Disease and Its Role in Hepatocellular Carcinoma: A Review of Novel Insights.
Mass Sanchez PB; Krizanac M; Weiskirchen R; Asimakopoulos A
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34067931
[TBL] [Abstract][Full Text] [Related]
48. Lack of ClC-2 Alleviates High Fat Diet-Induced Insulin Resistance and Non-Alcoholic Fatty Liver Disease.
Fu D; Cui H; Zhang Y
Cell Physiol Biochem; 2018; 45(6):2187-2198. PubMed ID: 29550812
[TBL] [Abstract][Full Text] [Related]
49. [Endoplasmic reticulum stress response and pathogenesis of non-alcoholic steatohepatitis].
Vallée D; Blanc M; Lebeaupin C; Bailly-Maitre B
Med Sci (Paris); 2020 Feb; 36(2):119-129. PubMed ID: 32129747
[TBL] [Abstract][Full Text] [Related]
50. The Effect of Low Glycemic Index and Glycemic Load Diets on Hepatic Fat Mass, Insulin Resistance, and Blood Lipid Panels in Individuals with Nonalcoholic Fatty Liver Disease.
Parker A; Kim Y
Metab Syndr Relat Disord; 2019 Oct; 17(8):389-396. PubMed ID: 31305201
[TBL] [Abstract][Full Text] [Related]
51. Curcumin Ameliorates Nonalcoholic Fatty Liver Disease through Inhibition of
Lee DE; Lee SJ; Kim SJ; Lee HS; Kwon OS
Nutrients; 2019 Nov; 11(11):. PubMed ID: 31717261
[TBL] [Abstract][Full Text] [Related]
52. Liver sympathetic denervation reverses obesity-induced hepatic steatosis.
Hurr C; Simonyan H; Morgan DA; Rahmouni K; Young CN
J Physiol; 2019 Sep; 597(17):4565-4580. PubMed ID: 31278754
[TBL] [Abstract][Full Text] [Related]
53. Rubicon inhibits autophagy and accelerates hepatocyte apoptosis and lipid accumulation in nonalcoholic fatty liver disease in mice.
Tanaka S; Hikita H; Tatsumi T; Sakamori R; Nozaki Y; Sakane S; Shiode Y; Nakabori T; Saito Y; Hiramatsu N; Tabata K; Kawabata T; Hamasaki M; Eguchi H; Nagano H; Yoshimori T; Takehara T
Hepatology; 2016 Dec; 64(6):1994-2014. PubMed ID: 27637015
[TBL] [Abstract][Full Text] [Related]
54. Angiotensin-(1-7), the product of ACE2 ameliorates NAFLD by acting through its receptor Mas to regulate hepatic mitochondrial function and glycolipid metabolism.
Song LN; Liu JY; Shi TT; Zhang YC; Xin Z; Cao X; Yang JK
FASEB J; 2020 Dec; 34(12):16291-16306. PubMed ID: 33078906
[TBL] [Abstract][Full Text] [Related]
55. Resveratrol prevents hepatic steatosis and endoplasmic reticulum stress and regulates the expression of genes involved in lipid metabolism, insulin resistance, and inflammation in rats.
Pan QR; Ren YL; Liu WX; Hu YJ; Zheng JS; Xu Y; Wang G
Nutr Res; 2015 Jul; 35(7):576-84. PubMed ID: 26055348
[TBL] [Abstract][Full Text] [Related]
56. miR-188 promotes liver steatosis and insulin resistance via the autophagy pathway.
Liu Y; Zhou X; Xiao Y; Li C; Huang Y; Guo Q; Su T; Fu L; Luo L
J Endocrinol; 2020 Jun; 245(3):411-423. PubMed ID: 32252024
[TBL] [Abstract][Full Text] [Related]
57. Roles of IκB kinases and TANK-binding kinase 1 in hepatic lipid metabolism and nonalcoholic fatty liver disease.
Huh JY; Saltiel AR
Exp Mol Med; 2021 Nov; 53(11):1697-1705. PubMed ID: 34848839
[TBL] [Abstract][Full Text] [Related]
58. Non-invasive assessment of hepatic lipid subspecies matched with non-alcoholic fatty liver disease phenotype.
Erickson ML; Haus JM; Malin SK; Flask CA; McCullough AJ; Kirwan JP
Nutr Metab Cardiovasc Dis; 2019 Nov; 29(11):1197-1204. PubMed ID: 31371265
[TBL] [Abstract][Full Text] [Related]
59. Maresin 1 attenuates NAFLD by suppression of endoplasmic reticulum stress via AMPK-SERCA2b pathway.
Jung TW; Kim HC; Abd El-Aty AM; Jeong JH
J Biol Chem; 2018 Mar; 293(11):3981-3988. PubMed ID: 29414781
[TBL] [Abstract][Full Text] [Related]
60. Lepr(db/db) Mice with senescence marker protein-30 knockout (Lepr(db/db)Smp30(Y/-)) exhibit increases in small dense-LDL and severe fatty liver despite being fed a standard diet.
Kondo Y; Hasegawa G; Okada H; Senmaru T; Fukui M; Nakamura N; Sawada M; Kitawaki J; Okanoue T; Kishimoto Y; Amano A; Maruyama N; Obayashi H; Ishigami A
PLoS One; 2013; 8(6):e65698. PubMed ID: 23755269
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
